| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.29 | 0.06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |